A New Analytical Method Development and Validation for Estimation
of Ciprofloxacin in Bulk and Pharmaceutical Dosage Form
Manoranjan Sabat*1,
Sharada Nalla1, Venkateswarlu
Goli1, Sravan Prasad Macherla2,
Praveena Kumari Matta2,
Madhu Chandaka S.2
1Venkateswara Institute of Pharmaceutical Seinces, Cherlapally, Nalgonda -508001.
2Sri Indu
Institute of Pharmacy, Sheriguda, Ibrahimpatnam,
R.R Dist. -501510
*Corresponding Author E-mail: sabatmanupharma10@gmail.com
ABSTRACT:
A sensitive, precise, accurate and simple
UV spectrophotometric method has been developed for estimation of ciprofloxacin
in bulk and pharmaceutical dosage form. The
drug shows maximum absorbance at 273 nm (λmax).
The linearity was observed in the concentration range of 5-50mcg/ml. The
proposed method has been applied successfully to the analysis of cited drug in
pharmaceutical formulation. Recovery study was performed to confirm the
accuracy of the method. The method was validated as per ICH guide lines.
KEYWORDS: Estimation, Ciprofloxacin, UV Spectrophotometer.
INTRODUCTION:
Ciprofloxacin is a broad spectrum
antibiotic active against gram +ve and gram –ve bacteria. It functions by inhibiting DNA gyrase [1,2], a type 2 topoisomerase
and type IV, enzymes necessary to separate bacterial DNA, there by inhibiting
cell division[2,4]. Ciprofloxacin is chemically 1-cyclopropyl-6- fluoro- 4-oxo- 7-(piperazin-1-yl)-quinoline
-3-carboxylic acid [5, 7]. Literature survey
reveals that no method has been reported for estimation of ciprofloxacin
satisfactorily. In The present investigation an attempt has been made to
develop a simple accurate, reproducible and economical spectrophotometric
method for the estimation of ciprofloxacin in tablet dosage form.
EXPERIMENTAL:
Material and
methods:
Elico SL210 uv-vis
double beam spectrophotometer with a pair of 1cm matched quartz cells was used.
Shimadzu BL- 220H analytical balance, Ciprofloxacin (Aurabindo
pharma Ltd.) and methanol of AR grade (S.D fine
chemicals) was used for the study.
Preparation of stock
solution:
Standard stock solution was prepared by
dissolving 10 mg of drug in 10 ml of distilled water to get concentration of
1000µg/ml solution. The stock solution was further diluted with distilled water
to get working standard solutions of 100µg/ml and 10µg/ml. to construct beer’s
lamberts plot for pure drug, different aliquots of ciprofloxacin were taken and
diluted to 10ml with distilled water. The absorbance was measured maximum at
273nm against distilled water as blank. The drug has obeyed beer’s limit in the
concentration range 5-60µg/ml.
Table 1: Linearity
table of ciprofloxacin in distilled water
Concentration (µg/ml) |
Absorbance |
5 |
0.362 |
10 |
0.721 |
20 |
1.412 |
30 |
2.113 |
40 |
2.802 |
50 |
3.600 |
Calibration curve
of ciprofloxacin
Estimation of ciprofloxacin in commercial
formulations
For analysis of commercial formulations, 20
tablets containing ciprofloxacin taken and powdered. The powder equivalent to
10mg of ciprofloxacin was taken in a 100ml volumetric flask, containing 70ml of
distilled water and sonicated for 30 minutes. The
volume was made up to 100 ml with distilled water and filtered to get a
concentration of 100µg/ml. This was further diluted with distilled water to get
a concentration within the linearity range. The values are substituted in
regression equation to get the percentage purity. The percentage purity found
to be 101.2%.
Table 2: RECOVERY
TABLE
Formulation |
Labeled amount |
Observed amount |
% Recovery |
%RSD |
Brand-I |
500mg |
506±0.33 |
101.2% |
4.612 |
Brand
-II |
500mg |
504±0.33 |
100.8% |
3.999 |
Table 3: PRECISION
Concentrations (µg/ml) |
Absorbance at 273nm |
Statistical analysis |
10 |
0.761 |
MEAN=0.7255 |
10 |
0.753 |
|
10 |
0.702 |
S.D=0.334664 |
10 |
0.732 |
|
10 |
0.696 |
%RSD=4.612 |
10 |
0.709 |
Table 4: ACCURACY
Samples |
Concentration(µg/ml) |
% Recovery |
Statistical analysis |
|
Pure drug |
Formulation |
|||
80% |
8 |
10 |
93% |
MEAN=96 SD=3.6 %RSD=3.75 |
80% |
8 |
10 |
100% |
|
80% |
8 |
10 |
95% |
|
100% |
10 |
10 |
97% |
MEAN=91 SD=6.55 %RSD=7.197 |
100% |
10 |
10 |
96% |
|
100% |
10 |
10 |
90% |
|
120% |
12 |
10 |
94% |
MEAN=96 SD=3.46 %RSD=3.604 |
120% |
12 |
10 |
100% |
|
120% |
12 |
10 |
94% |
Table 5: OPTICAL
CHARECTERISTICS:
OPTICAL CHARECTERS |
At 273nm |
Beer’s
law limit (µg/ml) |
5-50
µg/ml |
%RSD |
4.612 |
Correlation
coefficient |
0.999 |
Slope
(a) |
0.071 |
Intercept
(b) |
0.004 |
Regression
equation |
Y=0.071x-0.004 |
RESULTS AND DISCUSSION:
The proposed method for estimation of
ciprofloxacin dosage form was found to be accurate, simple and rapid. The
calibration and assay results were shown in table 1-5. The % RSD is found to be
less than 4, which indicates the validity of method. Linearity was observed by
regression equation for ciprofloxacin in different concentration range. The
assay results obtained by proposed method were precise; hence it can be used
for routine analysis of ciprofloxacin dosage form. There was no interference
from tablet excipients in this method. The method is
accurate, simple, rapid, precise, reliable, sensitive, reproducible and
economic and is validated as per ICH guidelines.
CONCLUSION:
Thus
the proposed method for the estimation of ciprofloxacin in the tablet dosage
forms was found to be rapid, sensitive, simple, accurate, and economical. High
percentage of recovery shows that the method is free from the interference of excipient (s) used in formulation. Therefore the method can
be useful in routine quality control of these drugs. The method was accurate
and having good prescion value.
REFERENCES:
1.
Drusano GL, Standiford HC, Plaisance K,
Forrest A, Leslie J, Caldwell J, GL (Sept 1986) “Absolute oral bioavailability
of ciprofloxacin” Anti microbe agents’ chemother. 30
(3): 444-6.
2.
“Ciprofloxacin- Hydrochloride”. The
American Society of Health-system Pharmacists.
Retrived 3 April 2011.
3.
“Flouroquinolone
drug class review”. Oregon State University college of Pharmacy 2002. Retrived Sept 9, 2011.
4.
Gomes GC, Salgado HRN. Validation of UV Spectrophotometry
method for determination of Lomifloxacin in
pharmaceutical dosage form. Acta Farm. Bonaerense, 2005; 24 (3): 406-408.
5.
Ross DL, Riley CM. Antibacterial effect
of Nalidixicacid derivatives. Intl. J. Pharm., 1990;
63: 237-240.
6.
Macor
JE. Annual Report in Medicinal
Chemistry, Vol 21.
London: Academic Press, 2007; p
331.
7. Guidance
for industry bioanalytical method validation. U.S
Dept. of Health and Human Services May 2001.
Received on 13.10.2012 Accepted on 12.11.2012
© Asian Pharma
Press All Right Reserved
Asian
J. Pharm. Ana. 2(4): Oct. - Dec. 2012; Page 116-117